AbbVie's Top Brass Escape Suit Over Rinvoq Claims, For Now
By Gina Kim · October 7, 2024, 10:29 PM EDT
An Illinois federal judge Friday tossed AbbVie investors' suit challenging directors' statements about the potential for its rheumatoid arthritis drug Rinvoq to be approved for other conditions, a possibility that collapsed...
To view the full article, register now.